• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Voyager PAD Trial - New Path for Post-revascularisation PAD Patients.

作者信息

Debus E Sebastian, Nehler Mark R

机构信息

University Heart Centre at University Medical Centre, Hamburg-Eppendorf, Hamburg, Germany.

University Heart Centre at University Medical Centre, Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Eur J Vasc Endovasc Surg. 2020 May;59(5):699-700. doi: 10.1016/j.ejvs.2020.03.041. Epub 2020 Apr 16.

DOI:10.1016/j.ejvs.2020.03.041
PMID:32307302
Abstract
摘要

相似文献

1
The Voyager PAD Trial - New Path for Post-revascularisation PAD Patients.旅行者PAD试验——血管再通术后PAD患者的新路径。
Eur J Vasc Endovasc Surg. 2020 May;59(5):699-700. doi: 10.1016/j.ejvs.2020.03.041. Epub 2020 Apr 16.
2
Editor's Choice - External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry.编辑精选——法国症状性下肢动脉疾病患者的 COMPASS 和 VOYAGER-PAD 试验的外部适用性：COPART 登记研究。
Eur J Vasc Endovasc Surg. 2021 Sep;62(3):439-449. doi: 10.1016/j.ejvs.2021.05.028. Epub 2021 Jul 28.
3
Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial.症状性外周动脉疾病的血运重建：VOYAGER PAD 试验的外部适用性。
Eur J Vasc Endovasc Surg. 2022 Feb;63(2):285-294. doi: 10.1016/j.ejvs.2021.10.026. Epub 2021 Dec 16.
4
Editor's Choice - Revascularisation for Peripheral Artery Disease in France: Implications for the Implementation of VOYAGER-PAD.编辑精选 - 法国外周动脉疾病的血运重建：对 VOYAGER-PAD 实施的影响。
Eur J Vasc Endovasc Surg. 2024 Jun;67(6):969-978. doi: 10.1016/j.ejvs.2024.01.091. Epub 2024 Feb 3.
5
VOYAGER PAD contributes to medical therapy for peripheral artery disease.Voyager PAD研究有助于外周动脉疾病的医学治疗。
J Vasc Surg. 2020 Dec;72(6):1843-1844. doi: 10.1016/j.jvs.2020.06.101.
6
Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.利伐沙班用于近期接受外周动脉血运重建术且有肾功能损害的患者：VOYAGER PAD试验
J Am Coll Cardiol. 2021 Aug 17;78(7):757-759. doi: 10.1016/j.jacc.2021.06.021.
7
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).血管结局研究的原理和设计，用于外周动脉疾病的血管内或手术肢体血运重建中与利伐沙班联合应用（VOYAGER PAD）。
Am Heart J. 2018 May;199:83-91. doi: 10.1016/j.ahj.2018.01.011. Epub 2018 Feb 3.
8
Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.低剂量利伐沙班联合阿司匹林用于接受下肢血管重建术的外周动脉疾病患者，伴或不伴有冠状动脉疾病：来自VOYAGER PAD研究的见解
Circulation. 2024 May 7;149(19):1536-1539. doi: 10.1161/CIRCULATIONAHA.124.068080. Epub 2024 May 6.
9
Rivaroxaban in Peripheral Artery Disease after Revascularization.利伐沙班治疗血管重建术后外周动脉疾病
N Engl J Med. 2020 May 21;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28.
10
Rivaroxaban in Peripheral Arterial Disease (PAD) Management.利伐沙班在周围动脉疾病（PAD）管理中的应用。
J Coll Physicians Surg Pak. 2023 Jul;33(7):832. doi: 10.29271/jcpsp.2023.07.832.

引用本文的文献

1
Antithrombotic Treatment Patterns of Patients with Symptomatic Peripheral Arterial Occlusive Disease in Germany: Evidence from Health Insurance Claims Data.德国有症状外周动脉闭塞性疾病患者的抗栓治疗模式：来自医疗保险理赔数据的证据
J Clin Med. 2022 Sep 16;11(18):5455. doi: 10.3390/jcm11185455.
2
Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials.口服抗凝和抗血小板治疗外周动脉疾病：随机对照试验的荟萃分析。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621996810. doi: 10.1177/1076029621996810.
3
Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation.
利伐沙班联合西洛他唑治疗老年体弱非瓣膜性心房颤动患者下肢严重缺血的长期疗效及安全性
J Pharm Health Care Sci. 2020 Aug 3;6:17. doi: 10.1186/s40780-020-00173-9. eCollection 2020.